Login / Signup

A new TGF-β risk score predicts clinical and immune landscape in colorectal cancer patients.

Bing TangBinggang LiuZhiyao Zeng
Published in: Annals of gastroenterological surgery (2024)
A CRC risk prognostic signature was developed on basis of TGF-β-related genes, which provides a reference for risk and further therapeutic selection of CRC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • transforming growth factor
  • patient reported outcomes
  • epithelial mesenchymal transition